Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,678,659
-$1,727,951 QoQ
Shares Held
1,059,831
-9.3% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $165,612,539 across 22 Drug Manufacturers - Specialty & Generic names. RDY ranks #3 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
912,970 | $107,922,182 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
124,479 | $16,398,863 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
This page
|
1,059,831 | $14,678,659 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
145,811 | $8,064,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
10,232 | $6,067,371 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
90,154 | $2,157,385 | |
| 7 | CGC |
Canopy Growth Corp
|
1,807,986 | $1,715,778 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
|
580,705 | $1,591,131 |
All Filings in RDY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,678,659 | 1,059,831 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,406,610 | 1,168,562 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,764,949 | 770,025 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,443,565 | 694,848 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,975,504 | 680,478 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,923,381 | 375,135 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,342,117 | 167,931 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,324,024 | 188,004 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,294,486 | 167,614 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $24,150,035 | 347,083 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,467,970 | 306,086 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,902,205 | 251,976 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $10,850,573 | 190,595 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,300,096 | 179,712 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,283,932 | 100,954 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,387,065 | 97,257 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $5,550,373 | 99,594 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,873,770 | 150,952 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $5,690,304 | 87,355 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,914,835 | 80,463 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,819,913 | 78,513 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $21,008,877 | 294,696 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $19,086,290 | 274,386 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,888,153 | 148,805 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,247,290 | 80,518 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||